Role of RIPK1 in SMAC mimetics-induced apoptosis in primary human HIV-infected macrophages

Ramon Edwin Caballero1,2, Simon Xin Min Dong3, Niranjala Gajanayaka4

  • 1Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. ramon.edwin.caballero@gmail.com.

Scientific Reports
|November 26, 2021
PubMed

Insights

Second mitochondrial activator of caspases (SMAC) mimetics induce apoptosis in HIV-infected macrophages by targeting inhibitor of apoptosis proteins (IAPs). This suggests IAP pathway modulation as a strategy to eliminate viral reservoirs.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Macrophages are crucial viral reservoirs for HIV due to resistance to apoptosis.
  • Inhibitor of apoptosis proteins (IAPs) contribute to this resistance against HIV-induced cell death.

Purpose of the Study:

  • To investigate the mechanism of SMAC mimetic-induced apoptosis in HIV-infected macrophages.
  • To explore the role of IAPs and RIPK1 in this process.

Main Methods:

  • Treatment of HIV-infected monocyte-derived macrophages (MDMs) with SMAC mimetics (SM).
  • Downregulation of IAPs using siRNAs.
  • Analysis of RIPK1 degradation and M1 phenotype acquisition.

Main Results:

  • SMAC mimetics induced apoptosis in HIV-infected MDMs, including ex-vivo samples.
  • SM-induced cell death was IAP-dependent and independent of M1 phenotype.
  • HIV infection led to RIPK1 degradation, potentially contributing to SM-induced apoptosis.

Conclusions:

  • SMAC mimetics selectively induce apoptosis in HIV-infected macrophages, possibly via RIPK1.
  • Modulating IAP pathways offers a potential therapeutic strategy for targeting HIV reservoirs.